Mounjaro Alternatives: Best Weight Loss Options if You Can't Get Mounjaro
Comprehensive UK guide to Mounjaro alternatives. Wegovy, Ozempic, Saxenda, Victoza, Orlistat, and other options compared—effectiveness, costs, availability, and which to choose.
Why You Might Need an Alternative
There are several reasons you might be looking for Mounjaro alternatives:
- Availability issues: Out of stock or supply constraints in your area
- Cost: Mounjaro may be too expensive; looking for cheaper options
- Side effects: Can't tolerate Mounjaro's GI effects
- Medical contraindications: Have conditions preventing Mounjaro use (thyroid cancer history, pregnancy, etc.)
- Personal preference: Prefer daily injection or oral medication vs weekly injection
- NHS/insurance coverage: Your coverage only funds certain alternatives
The good news: Several effective alternatives exist. While Mounjaro is currently the most effective, other medications still deliver significant, clinically meaningful weight loss.
Complete Comparison Table
| Medication | Type | Dosing | Avg Weight Loss | UK Cost/Month | NHS Available |
|---|---|---|---|---|---|
| Mounjaro (tirzepatide) | Dual GIP/GLP-1 | Weekly injection | 15-22% | £170-350 | Yes (very limited) |
| Wegovy (semaglutide) | GLP-1 agonist | Weekly injection | 12-15% | £180-320 | Yes (very limited) |
| Ozempic (semaglutide) | GLP-1 agonist | Weekly injection | 8-12%* | £180-250 | Yes (diabetes only) |
| Saxenda (liraglutide) | GLP-1 agonist | Daily injection | 5-8% | £180-250 | Yes (very limited) |
| Victoza (liraglutide) | GLP-1 agonist | Daily injection | 3-6%* | £70-120 | Yes (diabetes only) |
| Orlistat (Xenical/Alli) | Lipase inhibitor | 3x daily oral | 3-5% | £40-80 | Yes (limited) |
*Off-label use at lower dose than obesity indication
Tier 1 Alternatives: Closest to Mounjaro
Wegovy (Semaglutide 2.4mg)
BEST ALTERNATIVEWhat it is: GLP-1 receptor agonist (same class as Mounjaro, but single mechanism vs Mounjaro's dual). FDA/MHRA approved specifically for obesity.
Effectiveness:
Dosing: Weekly injection, starting 0.25mg, escalating to 2.4mg over 16-20 weeks
Side effects: Very similar to Mounjaro—nausea, diarrhoea, vomiting, constipation. Slightly less frequent/severe than Mounjaro on average.
Cost: £180-320/month privately (similar to Mounjaro)
UK availability: NHS approved (very limited). Privately: variable—supply issues 2023-2024, improving in 2025.
Pros:
- Second most effective option after Mounjaro
- Established safety profile
- Weekly injection (convenient)
- NHS approved (though hard to access)
Cons:
- Still expensive privately
- Supply can be unreliable
- Similar side effects to Mounjaro (if intolerant to one, may not tolerate this either)
Best for: People who can't get Mounjaro due to availability/cost but want maximum weight loss. Very similar experience to Mounjaro.
💡 Wegovy vs Mounjaro: If choosing between these two, Mounjaro wins on efficacy (5-7 percentage points more weight loss). But if Mounjaro is unavailable or unaffordable, Wegovy is an excellent alternative—still produces dramatic results for most users.
Tier 2 Alternatives: Moderately Effective Options
Saxenda (Liraglutide 3mg)
TIER 2What it is: GLP-1 agonist (older generation than semaglutide/tirzepatide). Licensed for obesity at 3mg dose.
Effectiveness:
Dosing: DAILY injection (vs weekly for Mounjaro/Wegovy). Start 0.6mg, escalate to 3mg over 5 weeks.
Side effects: Similar GI effects (nausea, diarrhoea) but often more tolerable than newer GLP-1s due to daily dosing (steadier levels).
Cost: £180-250/month privately
UK availability: NHS approved for obesity (very limited). Private: generally good availability.
Pros:
- Still clinically significant weight loss (5-8%)
- Daily injection allows more dose control (can adjust daily vs stuck with weekly dose)
- Generally good UK availability
- NHS approved option
Cons:
- Daily injections (less convenient than weekly)
- Less effective than Mounjaro/Wegovy
- Similar cost to Wegovy but less weight loss
Best for: People who prefer daily dosing for control, can't tolerate weekly injections, or need a stepping stone before higher-dose GLP-1s.
Ozempic (Semaglutide 0.5-1mg)
OFF-LABELWhat it is: Same drug as Wegovy (semaglutide) but lower dose (0.5-1mg vs 2.4mg), licensed for type 2 diabetes, NOT obesity.
Effectiveness:
Dosing: Weekly injection, 0.25mg start, escalate to 0.5mg or 1mg
Side effects: Same as Wegovy but potentially milder due to lower dose
Cost: £180-250/month privately (sometimes cheaper than Wegovy despite being lower dose—supply/demand dynamics)
UK availability: NHS available for type 2 diabetes only. Private: doctors may prescribe off-label for obesity.
Pros:
- Better availability than Wegovy historically
- Still produces good weight loss (8-12% at 1mg dose)
- Weekly injection
- Lower side effect burden than Wegovy 2.4mg
Cons:
- Off-label use (not approved for obesity at this dose)
- Less effective than Wegovy 2.4mg or Mounjaro
- Ethical concerns about diverting diabetes medication
Best for: People with type 2 diabetes who also need weight loss (on-label use), or as bridge when Wegovy unavailable (off-label). Not recommended as first choice for obesity alone.
⚠️ Note on Off-Label Ozempic Use
Using Ozempic for weight loss is controversial. It's licensed for diabetes, and using it for obesity diverts supply from diabetics who need it. Wegovy (same drug, higher dose) is the proper obesity formulation. Only consider Ozempic if: (1) you have diabetes, or (2) Wegovy is genuinely unavailable and doctor agrees to off-label use.
Tier 3 Alternatives: Less Effective but Still Helpful
Orlistat (Xenical/Alli)
TIER 3What it is: Lipase inhibitor (completely different mechanism). Blocks ~25% of fat absorption in gut. Oral medication, not injection.
Effectiveness:
Dosing: 120mg tablet, 3x daily with meals (or within 1 hour)
Side effects: GI effects BUT different from GLP-1s. Oily stools, flatulence, urgent bowel movements, fecal incontinence (if you eat high-fat foods). NOT nausea-based.
Cost: £40-80/month (significantly cheaper than GLP-1s)
UK availability: NHS available (more readily than GLP-1s). OTC lower dose (60mg as "Alli")
Pros:
- Much cheaper
- Easier NHS access
- Oral medication (no injections)
- Different mechanism (option if can't tolerate GLP-1s)
- Forces low-fat eating (immediate consequences if you cheat)
Cons:
- Significantly less effective (3-5% vs 15-22% with Mounjaro)
- Embarrassing side effects (oily leakage, accidents)
- 3x daily dosing
- Blocks fat-soluble vitamin absorption (need supplements)
Best for: Budget-conscious users, those who can't tolerate/access GLP-1s, or as stepping stone while awaiting better options. Requires strict low-fat diet compliance.
Victoza (Liraglutide 1.8mg)
OFF-LABELWhat it is: Same drug as Saxenda (liraglutide) but lower dose (1.8mg vs 3mg), licensed for type 2 diabetes, NOT obesity.
Effectiveness:
Dosing: Daily injection, escalate to 1.8mg
Cost: £70-120/month (cheaper than Saxenda due to diabetes indication)
Best for: Type 2 diabetics who also need weight loss (on-label). Not recommended as primary obesity treatment when Saxenda (proper dose) available.
Non-Medication Alternatives
Bariatric Surgery
Most effective long-term weight loss intervention (20-35% weight loss sustained 10+ years). Options:
- Gastric bypass: 25-35% weight loss, significant metabolic improvements
- Gastric sleeve: 20-30% weight loss, simpler procedure than bypass
- Gastric band: 10-20% weight loss, least invasive but less effective
NHS criteria: BMI ≥40 or ≥35 with serious comorbidities, documented failed weight loss attempts. Long waiting lists (1-3 years). Private: £8,000-15,000.
Structured Weight Management Programmes
Non-medication approaches via NHS Tier 2/3 services or private:
- Dietitian-led programmes
- Commercial programmes (Weight Watchers, Slimming World)
- Low-calorie meal replacement plans (e.g., 800-calorie Cambridge/VLCD programmes)
Effectiveness: 5-10% weight loss possible with high adherence, but higher dropout rates than medication.
Decision Tree: Which Alternative for You?
Choosing Your Mounjaro Alternative
→ Wegovy (semaglutide 2.4mg). Closest alternative, 12-15% loss, weekly injection, similar cost.
→ Saxenda (liraglutide 3mg). Daily dosing, 5-8% loss, may feel more tolerable than weekly.
→ Orlistat (different mechanism—no nausea, but GI effects if eating fat). Or consider non-medication approaches.
→ Ozempic (semaglutide 0.5-1mg) on-label. Or Mounjaro if available (treats both conditions excellently).
→ Orlistat (£40-80/month). Or NHS programmes (free but long waits). Sacrifice efficacy for affordability.
→ Bariatric surgery consideration. Most effective long-term but invasive and requires lifestyle commitment.
→ Structured programmes (NHS Tier 2/3, commercial plans, VLCD). Requires high motivation and adherence.
Frequently Asked Questions
Wegovy (semaglutide 2.4mg) is the closest alternative—weekly injection, similar mechanism (GLP-1 agonist), produces 12-15% weight loss vs Mounjaro's 15-22%. Costs similarly (£180-320/month UK), has comparable side effects. If Wegovy unavailable, Saxenda (daily injection, 5-8% loss) is next best medication alternative.
No. Ozempic is semaglutide at diabetes dose (0.5-1mg), licensed for type 2 diabetes. Mounjaro is tirzepatide (2.5-15mg) for weight loss/diabetes. Different drugs, different mechanisms (Ozempic is GLP-1 only; Mounjaro is dual GIP/GLP-1). Ozempic is less effective for weight loss (8-12% vs 15-22%).
Yes, for weight loss. Wegovy produces 12-15% weight loss vs Saxenda's 5-8%. Wegovy is also more convenient (weekly vs daily injection). However, Saxenda may be better tolerated by some people due to daily dosing (steadier levels). Cost is similar (£180-250/month).
Yes, but requires medical supervision. Both are GLP-1 agonists so transition is possible. Your doctor will create a plan—likely starting Wegovy at low dose and escalating, rather than direct dose conversion. Some weight regain possible during switch as Wegovy is less potent.
Orlistat is cheapest (£40-80/month privately, or NHS funded more readily than GLP-1s). However, it's also least effective (3-5% weight loss vs 15-22% with Mounjaro). You pay less but get less results. Balance cost vs effectiveness based on your budget and goals.
No supplement or "natural" product comes close to Mounjaro's effectiveness. Claims of natural GLP-1 boosters (berberine, etc.) are vastly exaggerated—at best 1-2% weight loss, often zero. Structured diet/exercise programmes, VLCD plans, and bariatric surgery are proven non-medication alternatives, but require significant lifestyle commitment.
The Bottom Line
Mounjaro is currently the most effective weight loss medication, but several alternatives exist if you can't access it:
- Best alternative: Wegovy (12-15% loss, weekly injection, similar cost)
- Second-best medication: Saxenda (5-8% loss, daily injection, good availability)
- Budget option: Orlistat (3-5% loss, oral medication, £40-80/month)
- Most effective non-medication: Bariatric surgery (20-35% loss but invasive)
Your choice depends on priorities: efficacy, cost, convenience (weekly vs daily), tolerability, and availability. For most people unable to get Mounjaro, Wegovy is the logical next choice—it's 85% as effective, works similarly, and if you could tolerate Mounjaro, you'll likely tolerate Wegovy.
However, don't feel limited to just medications. Combining any of these with structured programmes, nutrition counselling, and exercise support significantly improves outcomes. The medication is a tool; your commitment to lifestyle change determines long-term success.
Compare Mounjaro & Alternatives
See which UK providers offer multiple weight loss medications
Compare Options & Prices⚠️ Medical Disclaimer: This comparison is educational only. Choice of weight loss medication should be made with your prescribing doctor based on your medical history, conditions, budget, and preferences. Never switch medications without medical supervision. Effectiveness data represents clinical trial averages; individual results vary.